Next‐generation chimeric antigen receptors for T‐ and natural killer‐cell therapies against cancerYe Li(Nanjing University of Chinese Medicine), Hind Rafei(The University of Texas MD Anderson Cancer Center)Immunological ReviewsAugust 7, 202310.1111/imr.13255Cited by 31SaveCiteExport RISWatch citationsRelated PapersHuman iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity|Cell stem cell|2018|980Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial|Nature Medicine|2024|452